Lista de obras - Lucy Mcnamara - Dominio Público Uruguay

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.

artículo científico

Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.

artículo científico publicado en 2012

Ebola Surveillance - Guinea, Liberia, and Sierra Leone

artículo científico

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

artículo científico publicado en 2010

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

artículo científico publicado en 2011

Hematopoietic stem/precursor cells as HIV reservoirs.

artículo científico publicado en 2011

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

artículo científico publicado en 2017

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

artículo científico publicado en 2017

Interferon Alfa Therapy: Toward an Improved Treatment for HIV Infection

article

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016

artículo científico publicado en 2019

Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

artículo científico publicado en 2012

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

artículo científico publicado en 2017

Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017.

artículo científico publicado en 2017

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

artículo científico publicado en 2017

Safety of a meningococcal group B vaccine used in response to two university outbreaks

artículo científico publicado en 2017

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

artículo científico publicado en 2015

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

artículo científico publicado en 2017

The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic

artículo científico publicado en 2016

The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

artículo científico publicado en 2011

Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people

article

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

artículo científico publicado en 2014

Using Neisseria meningitidis genomic diversity to inform outbreak strain identification

scientific article published on 18 May 2021

Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis

artículo científico publicado en 2010

Lista de obras de Lucy Mcnamara

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.

Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.

Ebola Surveillance - Guinea, Liberia, and Sierra Leone

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

Hematopoietic stem/precursor cells as HIV reservoirs.

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

Interferon Alfa Therapy: Toward an Improved Treatment for HIV Infection

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016

Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017.

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

Safety of a meningococcal group B vaccine used in response to two university outbreaks

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic

The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

Using Neisseria meningitidis genomic diversity to inform outbreak strain identification

Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis